Search for Clinical Trial Results
Leukemia, T-cell, Chronic - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Ruxolitinib for Adult T-Cell Leukemia Condition:
Date: 2016-02-20 Interventions: Biological: IL-15 plus alemtuzumab rhIL-15 by s.c. injection Monday-Friday over two weeks; followed by a |
Completed |
Study Name: Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 Condition: Adult T-cell Leukemia-Lymphoma Date: 2010-07-30 Interventions:
|
Completed |
Study Name: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Condition: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Date: 2011-08-16 Interventions: Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Completed |
Study Name: Anti-Tac for Treatment of Leukemia Condition:
Date: 2000-01-18 Interventions: Biological: daclizumab Other Name: Zenapax |
Recruiting |
Study Name: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma Condition:
|
Terminated |
Study Name: Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma Condition:
Date: 2008-06-13 Interventions: Drug: Panobinostat (LBH589) 20mg/day p.o. on three times-a- week |
Completed |
Study Name: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) Condition: T-cell-prolymphocytic Leukemia Date: 2010-08-20 Interventions:
|
Terminated |
Study Name: Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma Condition:
Date: 2009-02-28 Interventions:
|
Completed |
Study Name: Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia Condition: Leukemia, Adult T-Cell Date: 2005-07-07 Interventions: Biological: Denileukin diftitox (Ontak) Patients will be treated with Denileukin Diftitox 9 mcg/kg/d int |